Search for other papers by M Boering in
Google Scholar
PubMed
Isala, Department of Internal Medicine, Zwolle, The Netherlands
Search for other papers by P R van Dijk in
Google Scholar
PubMed
Langerhans Medical Research group, Zwolle, The Netherlands
Search for other papers by S J J Logtenberg in
Google Scholar
PubMed
Department of General Practice, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Search for other papers by K H Groenier in
Google Scholar
PubMed
Search for other papers by B H R Wolffenbuttel in
Google Scholar
PubMed
Search for other papers by R O B Gans in
Google Scholar
PubMed
Langerhans Medical Research group, Zwolle, The Netherlands
Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Search for other papers by N Kleefstra in
Google Scholar
PubMed
Isala, Department of Internal Medicine, Zwolle, The Netherlands
Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
Search for other papers by H J G Bilo in
Google Scholar
PubMed
.1016/S0002-9343(97)89516-2 ) 22 Oskarsson PR Lins PE Backman L Adamson UC. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients . Diabetes & Metabolism 2000 26
Department of Medicine, Department of Biomedical Sciences, Department of Endocrinology, Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Kildegårdsvej 28, DK-2900 Hellerup, Denmark
Search for other papers by David P Sonne in
Google Scholar
PubMed
Department of Medicine, Department of Biomedical Sciences, Department of Endocrinology, Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Kildegårdsvej 28, DK-2900 Hellerup, Denmark
Search for other papers by Asger Lund in
Google Scholar
PubMed
Search for other papers by Jens Faber in
Google Scholar
PubMed
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Department of Medicine, Department of Biomedical Sciences, Department of Endocrinology, Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Kildegårdsvej 28, DK-2900 Hellerup, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Department of Medicine, Department of Biomedical Sciences, Department of Endocrinology, Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Kildegårdsvej 28, DK-2900 Hellerup, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
augmented, which, however, was not demonstrated in this study. Moreover, hypoglycaemia, which is known to suppress somatostatin levels, has also been shown to reduce TSH concentrations (35) , indicating that other factors apart from somatostatin are
Department of Endocrinology, Department of Molecular Medicine and Surgery, Metabolism and Diabetology, Karolinska University Hospital, 171 76 Stockholm, Sweden
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Erik Wahlström in
Google Scholar
PubMed
Search for other papers by Petra Tollet-Egnell in
Google Scholar
PubMed
Search for other papers by Gunnar Norstedt in
Google Scholar
PubMed
kg/m 2 , with verified severe GHD, defined by a GH peak response of <3 μg/l after insulin hypoglycaemia and arginine stimulation test. All patients had three to four additional pituitary insufficiencies and had been receiving a stable conventional
Search for other papers by P R van Dijk in
Google Scholar
PubMed
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Search for other papers by S J J Logtenberg in
Google Scholar
PubMed
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Search for other papers by K H Groenier in
Google Scholar
PubMed
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Search for other papers by N Kleefstra in
Google Scholar
PubMed
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Search for other papers by H J G Bilo in
Google Scholar
PubMed
Diabetes Centre, Departments of Internal Medicine, General Practice, Langerhans Medical Research Group, Department of Internal Medicine, Division of Cell Biology, Faculty of Health Sciences, Isala Clinics, PO Box 10400, 8000 G.K. Zwolle, The Netherlands
Search for other papers by H J Arnqvist in
Google Scholar
PubMed
/mol and/or ≥5 incidents of hypoglycaemia (<4.0 mmol/l) per week and treated with multiple daily injections (MDIs) or continuous s.c. insulin infusion (CSII)) were randomly allocated to continue their current s.c. mode of therapy or start with i.p. insulin
Search for other papers by Lia Ferreira in
Google Scholar
PubMed
Search for other papers by João Silva in
Google Scholar
PubMed
Search for other papers by Susana Garrido in
Google Scholar
PubMed
Search for other papers by Carlos Bello in
Google Scholar
PubMed
Search for other papers by Diana Oliveira in
Google Scholar
PubMed
Search for other papers by Hélder Simões in
Google Scholar
PubMed
Search for other papers by Isabel Paiva in
Google Scholar
PubMed
Search for other papers by Joana Guimarães in
Google Scholar
PubMed
Search for other papers by Marta Ferreira in
Google Scholar
PubMed
Search for other papers by Teresa Pereira in
Google Scholar
PubMed
Search for other papers by Rita Bettencourt-Silva in
Google Scholar
PubMed
Search for other papers by Ana Filipa Martins in
Google Scholar
PubMed
Search for other papers by Tiago Silva in
Google Scholar
PubMed
Search for other papers by Vera Fernandes in
Google Scholar
PubMed
Search for other papers by Maria Lopes Pereira in
Google Scholar
PubMed
Search for other papers by Adrenal Tumors Study Group of the Portuguese Society of Endocrinology in
Google Scholar
PubMed
asthenia (60.1%), mucocutaneous hyperpigmentation (55.0%), weight loss (43.2%), hypotension (42.8%) and hypoglycaemia (8.6%). Hyponatraemia was documented in 36.3% of cases, while hyperkalaemia occurred in 25.9%. AC was diagnosed in 29.1% of the patients
Search for other papers by E R Polina in
Google Scholar
PubMed
Search for other papers by F M Oliveira in
Google Scholar
PubMed
Search for other papers by R C Sbruzzi in
Google Scholar
PubMed
Search for other papers by D Crispim in
Google Scholar
PubMed
Department of Internal Medicine, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
Search for other papers by L H Canani in
Google Scholar
PubMed
Cardiovascular Research Laboratory, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil
Search for other papers by K G Santos in
Google Scholar
PubMed
, the overexpression of miR-155 resulted in hypoglycaemia, improved glucose tolerance and enhanced insulin sensitivity in peripheral tissues, which were caused, at least in part, by enhanced glucose uptake and enhanced glycolysis, whereas the deficiency
Search for other papers by Mark R Postma in
Google Scholar
PubMed
Search for other papers by Pia Burman in
Google Scholar
PubMed
Search for other papers by André P van Beek in
Google Scholar
PubMed
-induced hypoglycaemia (in 76% of cases), but in other cases by a weaker GH stimulation test like the arginine (in 9%), GHRH (in 6%), glucagon (in 1%), or other tests (in 8%). Patients were adequately replaced with all pituitary hormones except for GH. Excluded were
Search for other papers by Natacha Driessens in
Google Scholar
PubMed
Search for other papers by Madhu Prasai in
Google Scholar
PubMed
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Search for other papers by Christophe De Block in
Google Scholar
PubMed
Search for other papers by Eva Van Caenegem in
Google Scholar
PubMed
Search for other papers by Guy T’Sjoen in
Google Scholar
PubMed
Search for other papers by Frank Nobels in
Google Scholar
PubMed
Search for other papers by Christophe Ghys in
Google Scholar
PubMed
Search for other papers by Laurent Vroonen in
Google Scholar
PubMed
Search for other papers by Corinne Jonas in
Google Scholar
PubMed
Search for other papers by Bernard Corvilain in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
gastrointestinal symptoms. Hypotension was reported in 58% of cases, electrolyte disturbance in 46% and hypoglycaemia in 10%. Excluding patients younger than 18, median BMI at diagnosis was 23.5 kg/m² (IQR 20.1–27.0; min–max 14.5–43.8; n = 127). Figure 1
Search for other papers by Shams Ali Baig in
Google Scholar
PubMed
Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Search for other papers by Kashish Malhotra in
Google Scholar
PubMed
Search for other papers by Anagh Josh Banerjee in
Google Scholar
PubMed
Search for other papers by Mukunth Kowsik in
Google Scholar
PubMed
Search for other papers by Khushi Kumar in
Google Scholar
PubMed
Search for other papers by Fazna Rahman in
Google Scholar
PubMed
Search for other papers by Syeda Sabbah Batul in
Google Scholar
PubMed
Search for other papers by Mohammed Faraaz Saiyed in
Google Scholar
PubMed
Search for other papers by Vardhan Venkatesh in
Google Scholar
PubMed
Search for other papers by Pranav Viswanath Iyer in
Google Scholar
PubMed
Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Punith Kempegowda in
Google Scholar
PubMed
-authored ‘CoMICsLite: Insulin centenary Ep.1 - history of diabetes until the discovery of insulin’ and ‘CoMICs Lite Polycystic Ovary Syndrome (PCOS) Ep.2 : Fertility.’ PVI co-authored ‘CoMICs Episode 73: Hospital management of hypoglycaemia in adults with diabetes’ and
Search for other papers by Robert Rapaport in
Google Scholar
PubMed
Search for other papers by Jan M Wit in
Google Scholar
PubMed
Search for other papers by Martin O Savage in
Google Scholar
PubMed
optimise short stature management. The origin of the ISS designation The diagnosis of GH deficiency in children entered clinical practice in the late 1960s with the demonstration of GH release following stimulation by insulin-induced hypoglycaemia